Royalty Pharma Plc Stock Performance

Royalty Pharma Relative Risk vs. Return Landscape

If you would invest  3,854  in Royalty Pharma Plc on November 9, 2025 and sell it today you would earn a total of  556.00  from holding Royalty Pharma Plc or generate 14.43% return on investment over 90 days. Royalty Pharma Plc is currently generating 0.2278% in daily expected returns and assumes 1.1596% risk (volatility on return distribution) over the 90 days horizon. In different words, 10% of stocks are less volatile than Royalty, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Royalty Pharma is expected to generate 1.42 times more return on investment than the market. However, the company is 1.42 times more volatile than its market benchmark. It trades about 0.2 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Royalty Pharma Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Royalty Pharma Plc has a beta of -0.14 indicating as returns on the benchmark increase, returns on holding Royalty Pharma are expected to decrease at a much lower rate. During a bear market, however, Royalty Pharma Plc is likely to outperform the market. Additionally Royalty Pharma Plc has an alpha of 0.2578, implying that it can generate a 0.26 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Royalty Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Royalty Pharma Plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 42.15 43.31 44.47 Details

Intrinsic Valuation Low Real High 41.12 42.28 48.51 Details

Naive Forecast Low Next High 44.58 45.74 46.90 Details

8 Analysts Consensus Low Target High 43.77 48.10 53.39 Details

Royalty Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Royalty Pharma is not an exception. The market had few large corrections towards the Royalty Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Royalty Pharma Plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Royalty Pharma within the framework of very fundamental risk indicators.

Royalty Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Royalty Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Royalty Pharma Plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Royalty Pharma Price Density Drivers

Royalty Pharma Fundamentals Growth

When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.